Figure 5 | Scientific Reports

Figure 5

From: Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Figure 5

(a) The effect of CPT-CEF on cell viability of HT29 colon cancer cells and (b) The effect of CPT-CEF on cell viability of A549 lung cancer cells. Cells were treated with various concentrations of CPT-CEF, CPT, CEF and Fe3O4 for 48 h, and cell viability was assessed via MTT assay. CPT-CEF reduced cell viability in HT29 cells in a dose-dependent manner. Results (mean ± SD) were calculated as percent of corresponding control values. *P < 0.05 is significant. Statistical analysis was performed via ANOVA. Each point represents three independent experiments.

Back to article page